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ABSTRACT: Galacto-oligosaccharides (GOS) are used in infant formula to replace the health effects of human milk
oligosaccharides, which appear to be dependent upon the structure of the individual oligosaccharides present. However, a
comprehensive overview of the structure-specific effects is still limited as a result of the high structural complexity of GOS. In this
study, porous graphitic carbon (PGC) was used as the stationary phase during ultra-high-performance liquid chromatography−mass
spectrometry (UHPLC−MS). This approach resulted in the recognition of more than 100 different GOS structures in one single
run, including reducing and non-reducing GOS isomers. Using nuclear magnetic resonance-validated structures of GOS
trisaccharides, we discovered MS fragmentation rules to distinguish reducing isomers with a mono- and disubstituted terminal
glucose by UHPLC−PGC−MS. UHPLC−PGC−MS enabled effective recognition of structural features of individual GOS
components in complex GOS preparations and during, e.g., biological conversion reactions. Hence, this study lays the groundwork
for future research into structure-specific health effects of GOS.
KEYWORDS: galacto-oligosaccharides, preparative chromatography, tandem mass spectrometry, porous graphitic carbon,
liquid chromatography
1. INTRODUCTION
Postnatal nutrition has a lifelong impact on health and well-
being because it guides the development of complex
interactions between the intestinal microbiota and the
gastrointestinal immune system.1,2 Although breast milk is
still considered the gold standard, many types of infant formula
are nowadays commercially available for those infants for
which exclusive breastfeeding is not an option. Oligosacchar-
ides present in human milk (HMOs) function as prebiotics
and have a direct effect on immunity by supporting the
development of the gut barrier.3,4 Currently, only a limited
number of less complex HMOs, such as 2′-fucosyllactose
(2′FL), 3′-sialyllactose (3′SL), and lacto-N-tetraose (LNT),
are commercially available and applied in infant formula.5
Therefore, predominantly galacto-oligosaccharides (GOS) and
the less complex fructo-oligosaccharides (FOS) are used as
substitute to replace the health effects of HMOs in infant
formula.6
GOS are produced by hydrolysis and transgalactosylation of
lactose, in which the process is catalyzed by β-galactosidase.7
This results in galactose chains with a terminal reducing
glucose or galactose unit, varying in the degree of polymer-
ization (DP) from 2 to 8 and in the type of glycosidic linkage:
β(1−2), β(1−3), β(1−4), and β(1−6).7 Besides GOS with a
free anomeric carbon at the terminal position (reducing GOS),
also non-reducing GOS containing the structural motif α-D-
Glcp-(1↔1)-β-D-Galp or β-D-Glcp-(1↔1)-β-D-Galp have been
reported.8−10 The source of the enzyme has a large influence
on both the regioselectivity of the enzyme and the size of the
produced oligosaccharides, resulting in mixtures enriched in
either β(1−3)-, β(1−4)-, or β(1−6)-linked galactose resi-
dues.11 Because the applied enzymes vary in industry, several
structurally distinct GOS mixtures are commercially avail-
able.12,13
The prebiotic effects of GOS vary depending upon its
monomer composition, type of glycosidic linkage, and
DP.14−15,17−18 For example, previous in vitro studies with pig
and human fecal microbiota showed the preference of
microbiota for degradation of β(1−2) and β(1−3) linkages
over β(1−4) and β(1−6) linkages.14,15 In studies aiming on
restoring Bifidobacterium levels in antibiotic-disrupted micro-
biota from adults, GOS DP ≥ 4 was more efficient than GOS
DP ≤ 3.14 Also, immune effects are demonstrated to depend
upon the structure of GOS, because DP2 and DP3 were shown
to have a higher protective effect on the intestinal barrier
integrity than higher DPs.16 However, to date, there is little
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evidence of the exact relationship between the structure of
individual GOS components and their prebiotic and immune
effects,14−18 which could be partly explained by the lack of
high-throughput characterization methods, which enable the
recognition of individual GOS components in complex GOS
preparations and during, e.g., biological conversion reactions.
Over the past decade, several studies described the
characterization of GOS using techniques, such as hydrophilic
interaction chromatography (HILIC) coupled to mass
spectrometry (MS)13 and preparative HILIC of DP fractions
prior to 1H and 13C nuclear magnetic resonance (NMR)
analysis.9 The study by van Leeuwen et al.8 offers probably the
most comprehensive overview thus far of the different
components present in Vivinal GOS, a commercial GOS
mixture produced by a Bacillus circulans β-galactosidase.19
Preparative high-performance anion-exchange chromatography
combined with pulsed amperometric detection (HPAEC−
PAD) of DP fractions prior to 1H and 13C NMR analysis
revealed more than 40 different components.8 The employed
B. circulans β-galactosidase introduced β(1−2), β(1−3), β(1−
4), and β(1−6) elongations on the reducing glucose residue.
However, longer oligosaccharides (DP ≥ 4) were reported to
be mainly β(1−4) elongations of acceptor di- and
trisaccharides by β-D-Galp.8,11
Nonetheless, HPAEC-based characterization methods alone
might not be suitable for structure−function studies, in which
the complex relation between the structure of GOS and a
specific bioactivity is monitored. Co-elution of isomers and
GOS structures having a different DP hinders the annotation
of individual GOS.8 Labor-intensive size-exclusion chromato-
graphic (SEC) fractionation of GOS into its constituent DPs
prior to analysis will help but is not suitable for structure−
function studies. Porous graphitic carbon (PGC) chromatog-
raphy could potentially overcome this limitation. The retention
mechanism of this stationary phase is based on the size, type of
linkage, and resulting three-dimensional (3D) structure of
oligosaccharides.20 As such, PGC chromatography provides
adequate separation of GOS and HMOs and has a high
sensitivity.21,22 The excellent chromatographic resolution even
resulted in the partial separation of α- and β-anomers,23
although complicating the already complex elution pattern.
Reduction of the oligosaccharides prior to analysis avoids the
occurrence of such double peaks, while maintaining a good
separation of the different oligosaccharides.22
PGC with ultra-high-performance liquid chromatography
(UHPLC) is highly compatible with MS, which enables the
characterization of galacto-oligosaccharides based on m/z and
MS2 fragmentation spectra. Nonetheless, MS fragmentation
pathways of derivatized galacto-oligosaccharides are highly
complex and partly unknown.13,24 Hence, NMR generally
proves to be highly valuable for the conclusive characterization
of oligosaccharides.25
In this study, a high-throughput characterization method
was developed for GOS based on UHPLC−PGC−MS. Both
SEC and preparative UHPLC−PGC−MS were applied to
obtain pure isomers representing different isomer classes.
These isomers were analyzed with NMR to be able to connect
the structure to the observed MS2 fragmentation. The
developed characterization method will provide novel insight
in the complexity of GOS mixtures currently applied in infant
formula and ultimately will contribute to a better under-
standing of structure-specific health effects of GOS.
2. MATERIALS AND METHODS
2.1. Materials. Purified Vivinal GOS was kindly provided by
Friesland Campina DOMO (Beilen, Netherlands). Vivinal GOS was
fractionated to obtain purified Vivinal GOS with <3% (w/w, dry
matter) monomers and lactose. In short, the lactose present in Vivinal
GOS was hydrolyzed by lactase, followed by removal of the
monosaccharides by nanofiltration.
GOS DP3 standards β-3′-galactosyl-lactose, β-4′-galactosyl-lactose,
and β-6′-galactosyl-lactose were purchased from Carbosynth (Berk-
shire, U.K.).
2.2. Fractionation of Vivinal GOS. 2.2.1. Fractionation on DP
Using Size-Exclusion Chromatography. Vivinal GOS was fraction-
ated on DP by size-exclusion chromatography (SEC) using an AKTA
purifier system (GE Healthcare, Chicago, IL, U.S.A.). GOS (20 mg/
mL, 5 mL) was injected into three serially connected Hiload 26/60
Superdex 30 preparative grade columns, each with a column volume
of 300 mL (GE Healthcare). The temperature was set at 35 °C, and
the flow rate was set at 2.6 mL of H2O/min. A refractive index (RI)
detector (Shodex RI-72, Yokohama, Japan) was used to monitor the
elution. The eluent containing GOS was collected in 5 mL fractions
using a Frac-950 fraction collector (GE Healthcare). Subsequently,
fractions were analyzed using matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry (MALDI−TOF−MS) as
described previously26 to determine the molecular weight of GOS
present in the fractions. The fractions with a purity of at least 90%
according to the signal intensity as measured by MALDI−TOF−MS
were pooled. Fractions containing DP3, which eluted between 720
and 740 mL, of multiple runs were pooled and freeze-dried. On the
basis of the elution pattern and m/z, also DP1, DP2, DP4, DP5, DP6,
and DP ≥7 were combined per DP and freeze-dried. Weights
obtained per DP were used to determine the relative abundance of the
different DPs in purified Vivinal GOS.
2.2.2. Reduction of Purified GOS DP3. Prior to further
fractionation, 100 mg of purified GOS DP3 was subjected to
reduction conditions and subsequently purified by solid-phase
extraction (SPE). Freshly prepared 0.5 M sodium borohydride
(NaBH4) was added to GOS DP3 (1.25 mg/mL) in a ratio of 1:1 (v/
v) and incubated overnight at room temperature. Cartridges (bed
weight, 250 mg; column volume, 3 mL; Carbograph, Supelclean
ENVI carb; Sigma-Aldrich, St. Louis, MO, U.S.A.) were activated with
1.5 mL of 80:20 (v/v) acetonitrile (ACN)/H2O, followed by 4× 1.5
mL of H2O. The reduced GOS DP3 including non-reducing isomers
[(1−1) linkage] (10 mL) were loaded on the cartridge, after which
the cartridge was washed 2 times with 2 mL of H2O. Subsequently
reduced (including non-reducing) GOS DP3 were eluted with 2× 1.5
mL of 40:60 (v/v) ACN/H2O. Eluted reduced (including non-
reducing) GOS were dried at 30 °C under nitrogen gas, resolubilized
in H2O, and freeze-dried.
2.2.3. Fractionation of Reduced (Including Non-reducing) DP3
Using Preparative UHPLC−PGC−MS. Fractionation was performed
on a Waters preparative LC−MS system, equipped with a 2767
sample manager, 2545 quaternary gradient module, fluid organizer,
3100 mass detector, and 2998 photodiode array detector (Waters,
Milford, MA, U.S.A.). Reduced (including non-reducing) GOS DP3
(95 mg/mL, 0.5 mL) was centrifuged (5 min, 15000g) and injected
onto a PGC column (150 × 21.2 mm, 5 μm particle size, Hypercarb;
Thermo Scientific, San Jose, CA, U.S.A.). The flow rate was set at
18.34 mL/min. Mobile phase A consisted of ULC−MS water + 0.1%
(v/v) formic acid, and mobile phase B consisted of ACN + 0.1% (v/
v) formic acid. The gradient applied was as follows: 0−80.8 min, 3−
11% B; 80.8−95.3 min, 11−100% B; and 95.3−109.9 min, 100−3% B,
followed by equilibration at 3% B. Fractions of 6.1 mL were collected
and analyzed using analytical UHPLC−PGC−MS (see section 2.3.2).
Fractions were pooled on the basis of the retention time and MS2
fragmentation of the isomer present. Only fractions with a purity of
90% according to the signal intensity as measured by analytical
UHPLC−PGC−MS were pooled. Afterward, ACN was evaporated
under a stream of nitrogen gas and the remaining water phase was
freeze-dried.
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2.3. Characterization of Vivinal GOS DP3. 2.3.1. Determi-
nation of Monosaccharide Composition of Vivinal GOS DP3. The
monosaccharide composition of reduced (including non-reducing)
Vivinal GOS DP3 was determined using HPAEC−PAD. Prior to
analysis, reduced (including non-reducing) Vivinal GOS DP3 was
completely hydrolyzed using trifluoroacetic acid (TFA) and
subsequently dissolved in 2 M TFA (0.2 mg/mL). After an incubation
of 1 h at 121 °C, TFA was evaporated under a stream of air at 40 °C.
The dried sample was resolubilized in water (0.025 mg/mL) and
centrifuged (5 min, 15000g). A total of 10 μL of sample was injected
to an ICS5000 system (Dionex, Sunnyvale, CA, U.S.A.) with a
CarboPac PA-1 column (250 × 2 mm inner diameter), a CarboPac
PA guard column (25 × 2 mm inner diameter), and a ISC5000 ED
detector (Dionex) in the PAD mode. The flow rate was set at 0.4 mL/
min. Mobile phases A (0.1 M sodium hydroxide), B (1 M sodium
acetate in 0.1 M sodium hydroxide), and C (H2O) were used with the
following elution profile: 0−35 min, 100% C; 35.1−50 min, 100% A−
40% B; 50.1−55 min, 100% B; 55.1−63 min, 100% A; and 63.1−78
min, 100% C. Post-column addition of 0.5 M NaOH at 0.1 mL/min
was performed between 0 and 35 min and between 63.1 and 78 min.
Galactose and glucose standards were included in the analysis. The
data were analyzed using Chromeleon 7.0 (Thermo Scientific).
2.3.2. Analytical UHPLC−PGC−MS. Reduced (including non-
reducing) GOS DP3 isomers were analyzed on an Accela UHPLC
system (Thermo Scientific) coupled to a mass spectrometer (LTQ
Velos Pro ion trap MS, Thermo Scientific) as described elsewhere,
with some minor modifications.27 Samples (0.5 μL, 0.25 mg/mL)
were injected on a Hypercarb PGC column (3 μm particle size, 2.1 ×
150 mm) in combination with a Hypercarb guard column (3 μm
particle size, 2 × 10 mm, Thermo Scientific). As mobile phase A,
ULC−MS water + 0.1% (v/v) formic acid was used. Mobile phase B
consisted of ACN + 0.1% (v/v) formic acid. The flow rate was 300
μL/min. The solvents were eluted according to the following profile:
0−2 min, 3% B; 2−51.7 min, 3−11% B; 51.7−53.2 min, 11−100% B;
53.2−61 min, 100% B; 61−62.5 min, 100−3% B; and 62.5−70.3 min,
3% B. The temperatures of the autosampler and column oven were
controlled at 10 and 25 °C, respectively. ULC−MS water containing
3% ACN was used to wash the autosampler needle. DP3 standards β-
3-galactosyl-lactose, β-4-galactosyl-lactose, and β-6-galactosyl-lactose
were used for the identification of GOS isomers. Vivinal GOS was
analyzed to identify the DP3 isomers in the Vivinal GOS mixture.
Prior to analysis, both the standards and Vivinal GOS were reduced
and purified using a small-scale SPE method as described elsewhere.27
Data acquisition and processing were performed using Xcalibur
(version 2.2, Thermo Scientific).
2.3.3. NMR. GOS DP3 isomer fractions (approximately 100 μg)
were dissolved in 1 mL of 99.8% deuterium oxide (D2O) to exchange
all protons of the sugar hydroxyl groups with deuterium. The samples
were freeze-dried, dissolved in 0.7 mL of 99.8% D2O, and transferred
to a NMR tube. A small droplet of acetone was added on the top of
the inside of the tube as an internal standard. This droplet was
evaporated for 10 s and then mixed with the sample and set on δ =
2.225 ppm for 1H spectra and δ = 31.55 ppm for 13C spectra.
3. RESULTS
3.1. Vivinal GOS Is Highly Complex. The complete
Vivinal GOS preparation was analyzed using UHPLC−PGC−
MS after reduction of all reducing ends. Figure 1 shows the
presence of a large number of oligosaccharides in Vivinal GOS.
The structural complexity of Vivinal GOS becomes even more
apparent when the m/z values are selected for each DP (Figure
1), which shows the large variety of isomers per DP.
The non-reducing isomers containing a (1−1) linkage were
easily distinguished on the basis of a m/z difference of 2
because they could not be reduced by NaBH4. Non-reducing
DP3 isomers showed an overlap in retention time with
reducing DP3 isomers (Figure 2). When their relatively low
abundance is taken into account, most non-reducing DP3
isomers would not have been detected without reduction prior
to analysis. In total, UHPLC−PGC−MS of reduced Vivinal
GOS enabled the identification of 15 non-reducing and 23
reducing DP3 isomers.
Theoretically, each DP3 isomer could be further elongated
during GOS production by β-galactosidase via either a β(1−3),
β(1−4), β(1−6), or β(1−2) linkage, resulting in four distinct
DP4 isomers for each distinct DP3 isomer, in which the
number would be even higher when branching of the backbone
is taken into consideration. However, Vivinal GOS DP4 is
“only” composed of 21 reducing and 13 non-reducing isomers
(Figure 3), and Vivinal GOS DP5 is “only” composed of 24
reducing and 11 non-reducing isomers (Figure 4). This finding
confirms the presence of a homologue series, as reported in a
previous study,8 with longer oligosaccharides (DP ≥ 4)
presented by β(1−4) elongations of acceptor di- and
trisaccharides by β-D-Galp. Additionally, reducing isomers are
most dominant in each DP because they contributed to 86, 87,
and 84% of the peak areas of DP3, DP4, and DP5, respectively.
Figure 1. UHPLC−PGC−MS profile of reducing and non-reducing
Vivinal GOS and DP2−6 after selection of the appropriate m/z for
that DP. All elution profiles were normalized to the actual
contribution of each DP to the total mixture.
Figure 2. UHPLC−PGC−MS profile of Vivinal GOS DP3 with the
selection of (A) reducing [m/z 505 and 551 (M + FA)] and (B) non-
reducing [m/z 503 and 549 (M + FA)] isomers. The most abundant
peak in both chromatograms was set at 100%. Peak numbers
correspond to characterized GOS isomers in Table 1, with r being
reducing isomers and n being non-reducing isomers [(1−1) linked].
Journal of Agricultural and Food Chemistry pubs.acs.org/JAFC Article
https://dx.doi.org/10.1021/acs.jafc.0c02684
J. Agric. Food Chem. 2020, 68, 7800−7808
7802
For further characterization, the focus will be on DP3 because
it will also give us insights into the structures of higher DPs.
3.2. Characterization of Vivinal GOS DP3. Character-
ization of GOS DP3 isomers was based on analytical UHPLC−
PGC−MS covering all isomers. NMR analysis of pure isomers
representing different isomer classes was performed to link the
structures to the observed MS2 fragmentation. This provides
deeper insight into the fragmentation behavior of GOS.
Additionally, the constituent monomer composition was
determined using hydrolysis prior to HPAEC analysis. In the
following paragraphs, the characterization of various isomers
will be further described.
3.2.1. Characterization of Purified GOS DP3 Isomers
Using NMR. NMR is used for the characterization of GOS
DP3 isomers representing different isomer classes. The purity
of the isomers is of importance for NMR analysis. As a result of
the substantial overlap of isomers with different DP (Figure 1),
Vivinal GOS was first fractionated on size (DP) using SEC to
facilitate further fractionation on the isomer level. According to
the weight obtained per DP, their relative abundance in Vivinal
GOS was as follows: DP1, 2%; DP2, 11%; DP3, 46%; DP4,
25%; DP5, 10%; DP6, 4%; and DP > 7, 2%. The obtained
GOS DP3 pool was reduced and further fractionated by
preparative UHPLC−PGC−MS to obtain pure isomers.
Preparative UHPLC−PGC−MS showed a similar peak
resolution when compared to the analytical method (data
not shown). In total, four different GOS DP3 isomers
representing different isomer classes (4r, 13r, 21r, and 13n in
Figure 2) were obtained for further NMR analysis in sufficient
amount and purity.
From the NMR data, all 1H and 13C chemical shifts could be
determined for the four isolated structures (Table S1 of the
Supporting Information). The chemical shift patterns of the
two Gal residues B and C of structures 4r and 13r fit with data
expected for non-reducing terminal β-D-Galp residues. This
suggests a structure with two terminal Gal residues, indicating
a disubstituted glucitol residue A.8 For structure 4r, the glucitol
residue A showed H-2;C-2 and H-4;C-4 chemical shifts that
significantly shifted from the literature data for glucitol,28
indicating a disubstituted glucitol residue at positions O-2 and
O-4. The heteronuclear multiple-bond correlation (HMBC)
spectrum showed correlations between C H-1:C-1 and A H-
2:C-2 and between B H-1:C-1 and A H-4:C-4. These data fit
the structure β-D-Galp-(1→2)[β-D-Galp-(1→4)]Glc-ol. For
structure 13r, H-2:C-2 and H-6a/b:C-6 are significantly shifted,
indicating substitution at these positions. The HMBC
spectrum showed correlations between B H-1:C-1 and A H-
6a/b:C-6 and between C H-1:C-1 and A H-2:C-2, confirming
the disubstitution of glucitol residue A. These data lead to
structure β-D-Galp-(1→2)[β-D-Galp-(1→6)]-Glc-ol. Structure
21r showed only a shifted H-4;C-4 in the glucitol residue,
fitting a monosubstituted glucitol residue. Residue B showed a
chemical shift pattern matching a 4-substituted β-D-Galp
residue, while residue C matched with a terminal β-D-Galp
residue (Table S1 of the Supporting Information). These data
lead to a β-D-Galp-(1→4)-β-D-Galp-(1→4)-Glc-ol structure.
The NMR spectra of structure 13n matched exactly with data
for the non-reducing GOS structure β-D-Galp-(1→4)-α-D-
Glcp-(1↔1)-β-D-Galp reported previously.10
3.2.2. Ratio of Galactose and Glucose Monomers in
Vivinal GOS DP3. Theoretically both glucose and galactose
could be present at the reducing end of GOS, because lactose,
galactose, and glucose can serve as an acceptor for the
enzyme−galactose complex in the transgalactosylation reac-
tion.29 In contrast to NMR, UHPLC−PGC−MS analysis does
not allow for the conclusive differentiation between galactose
and glucose monomers. Therefore, the monosaccharide
composition of Vivinal GOS DP3 was determined using
hydrolysis prior to HPAEC analysis. Galactose and glucose are
present in a 2.1:1 ratio in Vivinal GOS DP3. This means that
only 3.4% of all GOS DP3 isomers is composed of three
galactose monomers. The preference for glucose or lactose as
an acceptor in the transgalactosylation reaction was supported
by previous in-depth characterization of Vivinal GOS, where
the presence of isomers with galactose at the reducing end was
limited to DP2.8 For further characterization using UHPLC−
PGC−MS, it is thus assumed that glucose is present at the
reducing end of the GOS DP3 isomers.
3.2.3. Characterization of DP3 Isomers Using UHPLC−
PGC−MS. Analytical UHPLC−PGC−MS was used for the
characterization of reducing and non-reducing GOS DP3
isomers present in Vivinal GOS. First of all, β-3′-galactosyl-
lactose (20r in Figure 2), β-4′-galactosyl-lactose (10r in Figure
2), and β-6′-galactosyl-lactose (18r in Figure 2) were
Figure 3. UHPLC−PGC−MS profile of Vivinal GOS DP4 with
selection of (A) reducing [m/z 667 and 713 (M + FA)] and (B) non-
reducing [m/z 665 and 711 (M + FA)] isomers. The most abundant
peak in both chromatograms was set at 100%. Peak numbers of the
reducing isomers (r) correspond to the different reducing GOS DP4
isomers in Table S3 of the Supporting Information. Peak numbers of
the non-reducing isomers (n) only present the different non-reducing
GOS DP4 isomers.
Figure 4. UHPLC−PGC−MS profile of Vivinal GOS DP5 with
selection of (A) reducing [m/z 829 and 875 (M + FA)] and (B) non-
reducing [m/z 827 and 873 (M + FA)] isomers. The most abundant
peak in both chromatograms was set at 100%. Peak numbers present
the different reducing (r) and non-reducing (n) GOS DP5 isomers.
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characterized on the basis of the comparison of the retention
time and MS2 fragmentation to those of the corresponding
commercial standards.
Linkage-specific cross-ring MS2 fragmentation was inves-
tigated to determine β(1−4) and β(1−6) linkages as described
in previous studies of GOS.30,31 The fragment ions are
described according to the nomenclature of Domon and
Costello.32 The presence of 0,2A2(−H2O) and the absence of
0,3A2 cross-ring fragments indicate β(1−4) linkages, whereas
the presence of 0,3A2 and the absence of
0,2A2(−H2O) cross-
ring fragments indicate β(1−6) linkages, with ions at m/z 263
for 0,2A2(−H2O) and m/z 251 for 0,3A2 cross-ring fragments in
negative ionization mode.30,31 These MS fragmentation rules
were confirmed by the MS fragmentation behavior of known
GOS DP3 structures present in pure form. Unfortunately,
these rules are only applicable for linkage identification at the
non-reducing end as a result of the disappearance of the ring
structure upon reduction. Nonetheless, these MS fragmenta-
tion rules resulted in the partial characterization of four
reducing isomers, 3r, 5r, 7r, and 14r (Figure 2), representing β-
D-Galp-(1→6)-β-D-Galp-(1→X)-D-Glc, β-D-Galp-(1→6)-β-D-
Galp-(1→X)-D-Glc, β-D-Galp-(1→4)-β-D-Galp-(1→3/6)-D-
Glc, and β-D-Galp-(1→6)-β-D-Galp-(1→X)-D-Glc, respec-
tively. MS2 fragmentation of GOS DP3 isomers is summarized
in Table S2 of the Supporting Information.
Furthermore, a comparison of the MS2 fragmentation
spectra of the selected isomers characterized by NMR, 4r,
21r, 10r, and 13r, resulted in MS fragmentation rules to
distinguish mono- and disubstitution of glucitol (Figure 5).
The dominance of a Z2 fragment with m/z 325 indicates
disubsitituted glucitol, whereas the dominance of the Y2
fragment with m/z 343 indicates monosubstituted glucitol
with two consecutive galactose units. In total, 7 of 23 reducing
GOS DP3 isomers are composed of disubstituted glucitol. The
fragmentation rule can also be applied to higher DPs. For
reducing GOS DP4 isomers, clear differences in relative
abundance were observed between Z3 (m/z 487) and Y3 (m/z
505) fragments in the mass spectra (Table S3 of the
Supporting Information). Interestingly, also for DP4, 7 isomers
with a disubstitution were detected. Additionally, PGC elution
patterns were comparable for DP3 and DP4, with on average
lower retention times for disubstituted isomers. Taking into
account the presence of a homologous series, these findings
suggest that, also for DP4, disubstitution is located at the
glucitol residue.
For the characterization of the non-reducing DP3 isomers,
the same cross-ring MS fragmentation rules were applied. MS2
fragmentation did not provide conclusive information on the
type of linkage or monomers present in each non-reducing
isomer. Nonetheless, in total, 6 non-reducing isomers with a
β(1−4) linkage and 2 non-reducing isomers with a β(1−6)
linkage were identified.
An overview of all conclusively and tentatively characterized
or unknown GOS isomers is shown in Tables 1 and 2 for
reducing and non-reducing isomers, respectively. Peak
numbers correspond to numbered peaks in Figure 2. In total,
29 of 38 reducing and non-reducing GOS DP3 isomers were
partially or completely characterized. The developed character-
ization method based on UHPLC−PGC−MS thus showed us
that Vivinal GOS DP3 is highly diverse.
4. DISCUSSION
The glycosidic linkage and DP of GOS affect their bioactivity,
as observed for fermentability and consequent health
effects,14−18 but solid evidence for these structure−function
relationships is still limited. This is partially due to the high
complexity of GOS with several GOS isomers present per DP.
In this study, a high-throughput characterization method based
on UHPLC−PGC−MS was developed to enable efficient
screening of structure-specific health effects of Vivinal GOS.
The method focuses on GOS DP3 isomers but will also
provide insight into the structure of higher DPs because it was
previously shown that higher DPs are mainly β(1−4)
elongations of DP3 isomers by β-D-Galp.8 Our study
corroborates this finding because the number of isomers
detected did not increase for DP4 and DP5.
UHPLC−PGC was shown to be highly valuable for the
recognition of the different isomers present in Vivinal GOS.
The complex retention mechanism of PGC based on both the
size and planarity of neutral oligosaccharides33 resulted in the
excellent separation of 38 GOS DP3 isomers. A previous study
using nano-PGC−LC only found 14 GOS DP3 isomers and
did not notice further characterization.22 Other chromato-
graphic techniques, such as HPAEC−PAD and HILIC−MS,
resulted in an inadequate separation because 11 and 5 GOS
DP3 isomers were detected, respectively.9,13 Also, for DP4 and
DP5, UHPLC−PGC surpassed the chromatographic resolu-
tion of the aforementioned techniques. In total, 34 and 35
GOS DP4 and DP5 isomers were separated using UHPLC−
Figure 5. Fragmentation spectra (ESI MS2) in negative mode of GOS
DP3 isomers (A) 4r, (B) 21r, (C) 10r, and (D) 13r. The proposed
routes of formation of the fragment ions, which are used to distinguish
reducing isomers with mono- and disubstituted glucitol, are indicated
in the spectra. The fragment ions are described according to the
nomenclature of Domon and Costello.32
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PGC, whereas less than 14 and 10 DP4 and DP5 isomers were
detected using HPAEC−PAD and HILIC−MS.9,13
NMR was used to characterize GOS DP3 isomers
representing different isomer classes. The combination of
SEC and preparative PGC−MS resulted in 4 pure isomers,
which were successfully characterized by NMR: the reducing
isomers β-D-Galp-(1→2)-[β-D-Galp-(1→4)-]D-Glc, β-D-Galp-
(1→4)-β-D-Galp-(1→2)-D-Glc, and β-D-Galp-(1→2)-[β-D-
Galp-(1→6)-]D-Glc and the non-reducing isomer β-D-Galp-
(1→4)-α-D-Glcp-(1↔1)-β-D-Galp. The characterized isomers
confirmed structures reported in previous studies.8,10 Con-
sequently, they will serve as “standards” to further develop the
high-throughput characterization method based on UHPLC−
PGC−MS. The laborious fractionation steps prior to analysis
would be unnecessary once having such a LC−MS method.
Reflection of the fragmentation behavior of the characterized
isomers led to the discovery of a MS fragmentation rule to
distinguish reducing isomers with mono- and disubstituted
glucitol. The type of linkage was determined using the linkage-
specific cross-ring MS2 fragments at the non-reducing end.30,31
These two MS fragmentation rules resulted in the partial
characterization of 23 of 38 GOS DP3 isomers. Interestingly,
Table 1. Overview of Conclusively and Tentatively Characterized or Unknown Reducing GOS DP3 Isomers
aIncluded for conclusively and tentatively characterized isomers: yellow, galactose; blue, glucose; and ?, unknown type of glycosidic linkage.
bDetermined by integration of peak areas in UHPLC−PGC−MS with the sum of both reducing and non-reducing DP3 isomers set at 100%. cX =
unknown.
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MS2 fragmentation spectra of GOS DP4 illustrated that the
fragmentation rules are also applicable to higher DPs for the
determination of the substitution of glucitol as well as for the
type of glycosidic linkages.
The clear-cut distinction between reducing and non-
reducing isomers on the m/z value made it a straightforward
approach to recognize the 15 GOS DP3 isomers with a (1−1)
linkage. A couple of non-reducing isomers have been reported
in previous studies regarding the characterization of Vivinal
GOS.8−10 However, these studies required labor-intensive
fractionation techniques prior to characterization of the non-
reducing isomers by NMR analysis. In this study, MS2
fragmentation analysis revealed 6 non-reducing DP3 isomers
with a (1−4) linkage. β(1−4)-linked galactose can be
connected to (1−1)-linked glucose as observed for isomer
13n: β-D-Galp-(1→4)-α-D-Glcp-(1↔1)-β-D-Galp. Next, it is
hypothesized that β(1−4)-linked galactose can also be
connected to (1−1)-linked galactose, resulting in α-D-Glcp-
(1↔1)-β-D-Galp-(4←1)-β-D-Galp. The study of Fransen et
al.10 corroborates this hypothesis because they reported on the
presence of non-reducing DP4 and DP5 GOS isomers
consisting of β(1−4)-linked galactose connected to a (1−1)-
linked galactose unit: β-D-Galp-(1→4)-α-D-Glcp-(1↔1)-β-D-
Galp-(4←1)-β-D-Galp and β-D-Galp-(1→4)-α-D-Glcp-(1↔1)-
β-D-Galp-(4←1)-β-D-Galp-(4←1)-β-D-Galp. The large variety
of non-reducing DP3 isomers can be further explained by the
presence of a structural motif containing solely β linkages, such
as β-D-Glcp-(1↔1)-β-D-Galp, as shown in previous research for
GOS DP2.9
The complete characterization of Vivinal GOS DP3 by
solely UHPLC−PGC−MS is still impeded by the challenge to
distinguish galactose/glucose and α/β linkages based on MS2
fragmentation. Furthermore, an optimal separation of the
numerous GOS structures on PGC demands reduction of the
reducing end prior to analysis, which results in the lack of
linkage-specific cross-ring fragments of resulting terminal
glucitol. More studies should be performed on alternative
labeling techniques of GOS to obtain both optimal chromato-
graphic separation and informative MS2 fragmentation spectra.
Nevertheless, the established high-throughput character-
ization method based on UHPLC−PGC−MS will already have
important implications for future structure−function studies
on GOS because it provides deeper insight in the complexity of
the GOS mixtures. In particular, the fragmentation rule to
distinguish mono- and disubstituted glucitol turned out to be
highly relevant because ongoing research revealed a difference
in resistance to fermentation by infant fecal microbiota (results
not shown).
The characterization method also shed light on the high
diversity of non-reducing GOS isomers. The identification of
non-reducing GOS isomers is hindered in currently used
methods as a result of their co-elution with more abundant
isomers. Hence, little is known about the fermentability and
health effects of these specific structures. To our knowledge,
only one study reported on the hydrolysis of non-reducing
GOS DP2 by bacterial enzymes.34 Nonetheless, with 12%, the
non-reducing isomers make up a considerable part of GOS
DP3 and can therefore not be ignored. UHPLC−PGC−MS
Table 2. Overview of Conclusively and Tentatively Characterized or Unknown Non-reducing GOS DP3 Isomers
aIncluded for conclusively characterized isomers: yellow, galactose; blue, glucose. bDetermined by integration of peak areas in UHPLC−PGC−MS
with the sum of both reducing and non-reducing DP3 isomers set at 100%. cX = unknown.
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readily facilitates incorporation in future structure−function
studies.
In summary, analytical UHPLC−PGC−MS has proven to
be a powerful tool to touch upon the high complexity of
Vivinal GOS. More than 100 different Vivinal GOS structures
were separated in one single run by the separation mechanism
of UHPLC−PGC−MS. In total, 23 reducing and 15 non-
reducing DP3 isomers were identified, which shows us that
Vivinal GOS is structurally much more diverse than previously
noticed. The established characterization method facilitates the
detection of non-reducing GOS and several structural features
of GOS, which could impact the fermentability by infant gut
microbiota. Hence, this study will contribute to a deeper
understanding of the structure-specific utilization of GOS by
infant gut microbiota and consequent health effects.
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